Willow Bark to Aspirin
The Folk Remedy That Became the World's Drug, Mostly
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The validation is real and the chain is documented: Reverend Edward Stone reported willow bark's fever-reducing power to the Royal Society in 1763; chemists isolated salicin from willow in 1828; and in 1897 Bayer's chemists (Felix Hoffmann and colleagues) produced acetylsalicylic acid, aspirin, one of the most widely used medicines in history, later shown by John Vane to work by blocking prostaglandin production. But historians add an honest caveat: the romantic claim that Hippocrates and the ancients clearly used willow specifically as an aspirin-like painkiller is shakier than usually told, several classic sources don't actually describe it that way. So willow-to-aspirin is a validated plant-to-drug story, with a useful lesson about not over-romanticizing traditional pedigrees.
Reference only. Not medical advice.
What can go wrong
Aspirin is effective but not harmless. It can cause stomach irritation, ulcers, and gastrointestinal bleeding, and it is linked to Reye's syndrome in children and teenagers during or after viral illness such as flu or chickenpox, which is why U.S. health agencies advise against aspirin in anyone under 19 during fever-causing illness. Willow bark supplements contain variable, unstandardized salicin and carry the same class of concerns, including bleeding, allergy in aspirin-sensitive people, interactions with anticoagulants and other NSAIDs, and the same pediatric Reye's caution, with far less dosing precision. Even the validated drug now carries a narrower primary-prevention role: in 2022 the USPSTF advised against starting aspirin for primary cardiovascular prevention in adults 60 and older because of bleeding risk. Anyone weighing willow bark or routine aspirin, especially children, pregnant people, or those on blood thinners or with ulcer history, should consult a qualified healthcare provider first.
Willow-to-aspirin is the classic case of a folk remedy becoming a global drug, and the core of it holds up, with two honest qualifications. Willow bark contains salicin, which the body converts to pain- and fever-reducing salicylic acid, and the documented modern chain is clear: Reverend Edward Stone's 1763 report to the Royal Society on willow bark for fevers, the isolation of salicin around 1828, and Bayer's 1897 synthesis of acetylsalicylic acid, aspirin. John Vane worked out how it acts in 1971, which helped earn him a share of the 1982 Nobel Prize. The first qualification is historical: the widely repeated claim that Hippocrates used willow as an aspirin-like painkiller is far shakier than usually told, and salicylate-bearing plants show up earlier in Sumerian and Egyptian records anyway. The second is practical: the validated product is standardized aspirin, and where willow bark has decent trial support it is standardized extract at a set salicin dose, not the romantic bark tea.
Willow bark eased pain and fever in many cultures and led to aspirin, one of history's great drugs, though the "ancient Hippocratic willow painkiller" pedigree is more legend than the tidy story suggests.
How it is supposed to work
Willow bark contains salicin, which the body converts to salicylic acid, the compound that reduces pain, fever, and inflammation by inhibiting cyclooxygenase enzymes. Aspirin (acetylsalicylic acid), synthesized by modifying salicylic acid, works through the same final pathway, which is why the folk remedy and the drug are genuinely related.
What people get wrong
Often saidAspirin is just purified willow bark that the ancients always used as a painkiller.
ActuallyThe salicin-to-salicylic-acid link is real, but the popular 'Hippocrates prescribed willow for pain' story is largely mythologized. Pharmacologist Philippa Martyr notes the Hippocratic corpus contains essentially one willow reference, for uterine fumigation rather than analgesia. Salicylate plants do appear earlier in Sumerian and Egyptian records. And Bayer's aspirin was made from salicylic acid synthesized industrially from phenol, not squeezed from willow.
Often saidWillow bark tea is a safer, natural aspirin.
ActuallyWillow bark carries variable, unstandardized salicin and the same class of risks as aspirin, including bleeding, allergy, and the pediatric Reye's syndrome concern. Memorial Sloan Kettering states children should not be given willow bark because of Reye's risk and that a direct benefit comparison with aspirin cannot be made. The trial support that exists is for standardized extract at a set salicin dose, not casual tea or bark chewing.
Often saidWillow bark has no real evidence, only tradition.
ActuallyThat undersells the standardized product. A confirmatory RCT (Chrubasik et al., Am J Med 2000, n=210) found standardized willow bark extract at 240 mg salicin per day left 39% of low back pain patients pain-free versus 6% on placebo, and a 2009 systematic review graded this as moderate evidence for low back pain. The evidence is real but modest and specific to standardized extract, and it is weaker or negative for osteoarthritis and rheumatoid arthritis.
Who profits, and who pushes back
Pharmacology historians
Trace a documented path from willow's salicin through Edward Stone's 1763 fever report and salicin's 1828 isolation to Bayer's 1897 aspirin, one of the most successful drugs ever.
Critical historians
Note that several classic sources cited for ancient willow-as-painkiller don't actually describe that use, warning against over-romanticizing the remedy's antiquity.
John Vane and pharmacologists
Showed aspirin works by inhibiting prostaglandin production, explaining the shared pain-fever pathway between the folk remedy and the drug.
Safety/pediatric clinicians
Warn that both aspirin and willow bark can cause bleeding and are linked to Reye's syndrome in children, and that willow's unstandardized dose adds uncertainty.
Where the research comes from
Most of the published research on this comes from one place. 100% of it is from Aspirin, one of the most-used drugs on earth. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Aspirin, one of the most-used drugs on earth | 100% |
How we got here
Salicylate-bearing plants were used for aches, inflammation, and fever long before Europe, and the record points east and south first. Sumerian tablets from roughly 2000 BC and the Egyptian Ebers Papyrus from about 1500 BC list willow and myrtle for pain and inflammation, myrtle actually carrying more salicin than willow. The romantic Greek pedigree is the weakest link: the Hippocratic corpus contains essentially one willow reference, and it concerns fumigation of the uterus, not a painkiller, so the tidy 'Hippocrates prescribed willow for pain' story is largely later invention. The documented modern arc is firmer. Reverend Edward Stone described willow bark for agues and fevers to the Royal Society in 1763, salicin was isolated from bark around 1828, and Bayer produced acetylsalicylic acid, aspirin, in 1897, trademarking the name in 1899. Vane's 1971 identification of prostaglandin inhibition finally explained why it works.
- c. 2000 BCSumerian tablets list willow and myrtle among remedies for illness and inflammation
- c. 1500 BCEgyptian Ebers Papyrus records willow and dried myrtle for aches and pain
- Antiquity (Greece)Willow appears in the Hippocratic corpus essentially once, for uterine fumigation, not as a painkiller; the 'ancient willow painkiller' pedigree is largely later legend
- 1763Rev. Edward Stone reports willow bark for agues and fevers to the Royal Society, based on treating about 50 people over five years
- 1828Salicin isolated from willow bark (Johann Buchner; some sources cite 1827), with larger yields by Leroux in 1829
- 1859Hermann Kolbe describes a synthesis of salicylic acid from phenol (later industrialized as the Kolbe-Schmitt process), enabling cheap synthetic salicylate
- 1897Bayer produces acetylsalicylic acid; the Hoffmann versus Eichengrun credit dispute stems from this work
- 1899Bayer registers the trademark 'Aspirin' for acetylsalicylic acid
- 1971John Vane shows aspirin acts by inhibiting cyclooxygenase and prostaglandin synthesis
- 1982Vane shares the Nobel Prize in Physiology or Medicine for prostaglandin-related work
- 1980sReye's syndrome link prompts warnings against aspirin in children with viral illness; U.S. OTC labeling warning follows
- 2022USPSTF advises against starting aspirin for primary cardiovascular prevention in adults 60 and older, citing bleeding risk
How it is understood
Willow (Salix) bark and leaves have been chewed and brewed for pain and fever in many cultures, willow grows almost everywhere, and references appear across Egyptian, Assyrian, Chinese, and European folk medicine. It is the classic story told to give modern aspirin an ancient, trustworthy pedigree: "people knew willow eased pain for thousands of years." That story is mostly, but not entirely, true, and the honest version is more interesting.
At a glance
- Active compound
- Salicin, becomes salicylic acid
- Key documented step
- Edward Stone's 1763 Royal Society report
- Aspirin synthesized
- 1897 (Bayer / Hoffmann)
- Honest caveat
- "Ancient willow painkiller" partly mythologized
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Willow Bark to Aspirin. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
Edward Stone's 1763 willow bark report to the Royal Society, treating agues and fevers in about 50 people
Scholarly commentary on Stone 1763, the modern arc, and the historical accuracy of ancient willow claims
Desborough & Keeling, 'From plant extract to molecular panacea,' Phil. Trans. R. Soc. B (2015), PMC
The 'Hippocrates used willow as a painkiller' pedigree is largely myth; one willow reference (uterine fumigation); salicin hard to dose from bark
Standardized willow bark extract at 240 mg salicin/day for low back pain: 39% pain-free vs 6% placebo, P<0.001, n=210
Moderate evidence for willow bark extract in low back pain; conflicting for osteoarthritis; negative for rheumatoid arthritis
Willow bark salicin content, mixed clinical evidence, cannot be directly compared to aspirin, Reye's and bleeding risks
Memorial Sloan Kettering Cancer Center, About Herbs: Willow Bark
Aspirin acts by inhibiting cyclooxygenase and prostaglandin synthesis (Vane 1971); 1982 Nobel Prize
The Nobel Prize in Physiology or Medicine 1982, NobelPrize.org
Hoffmann synthesized ASA on 10 August 1897; Eichengrun credit dispute; 1934 footnote claim; Nazi-era context
Arthur Eichengrun, Wikipedia (with cited primary and secondary references)
Bayer trademarked 'Aspirin' on 6 March 1899; salicylic acid synthesized via Kolbe route from phenol; name origin from Spiraea/meadowsweet
Standardized aspirin preferable to willow extract; store willow cannot match aspirin; acetyl group underlies antiplatelet action
Schwarcz, 'Forget the Willow Bark Extract, Go For Aspirin,' McGill Office for Science and Society
FDA Reye's syndrome warning labeling for OTC aspirin and salicylates in children and teenagers
U.S. Federal Register, Reye's Syndrome Warning labeling rule (2003)
2022 USPSTF: recommends against starting aspirin for primary CVD prevention in adults 60+, individualized for 40-59, citing bleeding risk
USPSTF Recommendation Statement, 'Aspirin Use to Prevent Cardiovascular Disease' (2022), PubMed
Salicin isolation around 1828 by Buchner; salicylic acid development; canonical aspirin timeline
'The history of aspirin, from willow bark to world wars and the Nobel prize,' Chemistry World
Ancient salicylate-plant use in Sumerian and Egyptian (Ebers Papyrus) records, myrtle and willow, predating Greek accounts